Dachaigh › Leucemia-Liomfa Lymphoblastach Cealla T Ro-ghnìomhach
Sgrùdaidhean clionaigeach Leucemia-Liomfa Lymphoblastach Cealla T Ro-ghnìomhach a’ fastadh anns na SA
Tha 23 sgrùdaidhean airson Leucemia-Liomfa Lymphoblastach Cealla T Ro-ghnìomhach a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX8 sgrùdaidhean
- New York City, NY6 sgrùdaidhean
- Columbus, OH5 sgrùdaidhean
- Washington, DC4 sgrùdaidhean
- Philadelphia, PA4 sgrùdaidhean
- Baldwin Park, CA3 sgrùdaidhean
- St. Louis, MO3 sgrùdaidhean
- Boston, MA3 sgrùdaidhean
- New Rochelle, NY3 sgrùdaidhean
- Queens, NY3 sgrùdaidhean
- Edison, NJ3 sgrùdaidhean
- East Norwalk, CT3 sgrùdaidhean
- Staten Island, NY3 sgrùdaidhean
Le stàit
- California5 sgrùdaidhean
- Colorado3 sgrùdaidhean
- Florida3 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- Missouri3 sgrùdaidhean
- New Jersey3 sgrùdaidhean
- New York7 sgrùdaidhean
- North Carolina3 sgrùdaidhean
- Ohio6 sgrùdaidhean
- Pennsylvania5 sgrùdaidhean
- Tennessee3 sgrùdaidhean
- Texas8 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06904066A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
A’ fastadhÌre 2
6 Months · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06514794Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT04301076Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT01087333A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
A’ fastadhÌre 2
1 Month – 21 Years · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06561074Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05289687Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
A’ fastadhÌre 1
Suas gu aois 39 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT04972942Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
A’ fastadhÌre 1
Aoisean 12 gu 30 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07513129Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
A’ fastadhÌre 1
Suas gu aois 75 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT03081910Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
A’ fastadhÌre 2
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06390319Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 15 Iuch 2026 · NCT00501826Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
A’ fastadhÌre 1
Aoisean 0 gu 29 · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT06934382Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825A Registry for People With T-cell Lymphoma
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT05978141CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04318678Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
A’ fastadhÌre 1
Suas gu aois 75 · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT07220993Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT07356245Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT05996185A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT06698003Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Gearr 2026 · NCT04848064Two Step Haplo With Radiation Conditioning
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Dàmh 2025 · NCT05031897Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 27 Dàmh 2025 · NCT01137643Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2025 · NCT06462365Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.